212 related articles for article (PubMed ID: 21984806)
21. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
22. Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.
Almejun MB; Cols M; Zelazko M; Oleastro M; Cerutti A; Oppezzo P; Cunningham-Rundles C; Danielian S
Eur J Immunol; 2013 Mar; 43(3):805-14. PubMed ID: 23225259
[TBL] [Abstract][Full Text] [Related]
23. Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.
Dickinson GS; Sun G; Bram RJ; Alugupalli KR
Infect Immun; 2014 Jan; 82(1):453-9. PubMed ID: 24218480
[TBL] [Abstract][Full Text] [Related]
24. mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.
Sintes J; Gentile M; Zhang S; Garcia-Carmona Y; Magri G; Cassis L; Segura-Garzón D; Ciociola A; Grasset EK; Bascones S; Comerma L; Pybus M; Lligé D; Puga I; Gutzeit C; He B; DuBois W; Crespo M; Pascual J; Mensa A; Aróstegui JI; Juan M; Yagüe J; Serrano S; Lloreta J; Meffre E; Hahne M; Cunningham-Rundles C; Mock BA; Cerutti A
Nat Commun; 2017 Nov; 8(1):1462. PubMed ID: 29133782
[TBL] [Abstract][Full Text] [Related]
25. Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.
Jabara HH; Lee JJ; Janssen E; Ullas S; Liadaki K; Garibyan L; Benson H; Sannikova T; Bram R; Hammarstrom L; Cruz AC; Siegel R; Manis J; Malley R; Geha RS
J Allergy Clin Immunol; 2017 Apr; 139(4):1293-1301.e4. PubMed ID: 27609654
[TBL] [Abstract][Full Text] [Related]
26. TACI Contributes to
Parra M; Yang J; Weitner M; Derrick S; Yang A; Schmidt T; Singh B; Moreno A; Akkoyunlu M
Front Immunol; 2018; 9():2612. PubMed ID: 30473702
[TBL] [Abstract][Full Text] [Related]
27. TACI expression and plasma cell differentiation are impaired in the absence of functional IκBNS.
Khoenkhoen S; Erikson E; Ádori M; Stark JM; Scholz JL; Cancro MP; Pedersen GK; Karlsson Hedestam GB
Immunol Cell Biol; 2019 May; 97(5):485-497. PubMed ID: 30597621
[TBL] [Abstract][Full Text] [Related]
28. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
29. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
[TBL] [Abstract][Full Text] [Related]
30. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
31. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
[TBL] [Abstract][Full Text] [Related]
32. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
33. TACI Isoforms Regulate Ligand Binding and Receptor Function.
Garcia-Carmona Y; Ting AT; Radigan L; Athuluri Divakar SK; Chavez J; Meffre E; Cerutti A; Cunningham-Rundles C
Front Immunol; 2018; 9():2125. PubMed ID: 30333819
[TBL] [Abstract][Full Text] [Related]
34. Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells.
Savage HP; Yenson VM; Sawhney SS; Mousseau BJ; Lund FE; Baumgarth N
J Exp Med; 2017 Sep; 214(9):2777-2794. PubMed ID: 28698287
[TBL] [Abstract][Full Text] [Related]
35. TACI attenuates antibody production costimulated by BAFF-R and CD40.
Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
[TBL] [Abstract][Full Text] [Related]
36. CVID-associated TACI mutations affect autoreactive B cell selection and activation.
Romberg N; Chamberlain N; Saadoun D; Gentile M; Kinnunen T; Ng YS; Virdee M; Menard L; Cantaert T; Morbach H; Rachid R; Martinez-Pomar N; Matamoros N; Geha R; Grimbacher B; Cerutti A; Cunningham-Rundles C; Meffre E
J Clin Invest; 2013 Oct; 123(10):4283-93. PubMed ID: 24051380
[TBL] [Abstract][Full Text] [Related]
37. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
[TBL] [Abstract][Full Text] [Related]
38. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
Angelin-Duclos C; Cattoretti G; Lin KI; Calame K
J Immunol; 2000 Nov; 165(10):5462-71. PubMed ID: 11067898
[TBL] [Abstract][Full Text] [Related]
39. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
